Clinical Trial Update: Parkinson's Disease Therapy Using Cell Technology [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for a Parkinson's disease therapy using mesenchymal stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Mesenchymal stem cell transplantation (mesenchymal stem cells)

Snippet

Sponsor: Belarusian Medical Academy of Post-Graduate Education | Conditions: Transplantation:Mesenchymal Stem Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN